BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38232644)

  • 1. Radix Tetrastigma Hemsleyani Flavone represses cutaneous squamous cell carcinoma via Janus kinase/signal transducer and activator of transcription 3 pathway inactivation.
    Peng J; Luo X; Wang T; Yue C; Duan M; Wu C
    Cytokine; 2024 Mar; 175():156480. PubMed ID: 38232644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radix Tetrastigma Hemsleyani Flavone Suppresses Cutaneous Squamous Cell Carcinoma A431 Cells via Proteasome Inhibition.
    Zhong L; Yang X; Zhu Y; Peng J; Cao Y
    Med Sci Monit; 2019 Jan; 25():436-442. PubMed ID: 30643111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radix tetrastigma hemsleyani flavone induces apoptosis in human lung carcinoma a549 cells by modulating the MAPK pathway.
    Zhong LR; Chen X; Wei KM
    Asian Pac J Cancer Prev; 2013; 14(10):5983-7. PubMed ID: 24289612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radix
    Wu X; Yu N; Zhang Y; Ye Y; Sun W; Ye L; Wu H; Yang Z; Wu L; Wang F
    Onco Targets Ther; 2018; 11():6437-6446. PubMed ID: 30323621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic analysis of miR-4792 regulates
    Liu P; Pu J; Zhang J; Chen Z; Wei K; Shi L
    Onco Targets Ther; 2019; 12():1401-1412. PubMed ID: 30863107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radix Tetrastigma hemsleyani flavone inhibits proliferation, migration, and invasion of human lung carcinoma A549 cells.
    Zhong L; Zheng J; Sun Q; Wei K; Hu Y
    Onco Targets Ther; 2016; 9():635-41. PubMed ID: 26893573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
    Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
    Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
    Zuo S; Li X; Bao W; Li S
    Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of extract of radix tetrastigma hemsleyani on apoptosis of human lung carcinoma H1299 cells and its mechanism study].
    Zhong LR; Lin S; Chen WF; Wei KM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Nov; 34(11):1354-8. PubMed ID: 25566628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
    Sen B; Saigal B; Parikh N; Gallick G; Johnson FM
    Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
    Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
    Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
    Xia Y; Chang X; Lian S; Zhu W
    J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of photodynamic therapy using Red LED-light combined with hypocrellin B on apoptotic signaling in cutaneous squamous cell carcinoma A431 cells.
    Liu Y; Cao Z; Wei G
    Photodiagnosis Photodyn Ther; 2023 Sep; 43():103683. PubMed ID: 37390854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway.
    Tian K; Liu W; Zhang J; Fan X; Liu J; Zhao N; Yao C; Miao G
    Cell Mol Biol Lett; 2020; 25():12. PubMed ID: 32161621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of change in microRNA expression profiles of lung cancer A549 cells treated with Radix tetrastigma hemsleyani flavonoids.
    Liu P; Yang X; Zhang H; Pu J; Wei K
    Onco Targets Ther; 2018; 11():4283-4300. PubMed ID: 30100735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway.
    Fang Y; Zhang S; Yin J; Shen YX; Wang H; Chen XS; Tang H
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3694-3700. PubMed ID: 32329845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
    Jacków J; Rami A; Hayashi R; Hansen C; Guo Z; DeLorenzo D; Pappalardo A; Alvarez Cespedes D; Kim AL; Perez-Lorenzo R; Owens DM; Christiano AM
    J Invest Dermatol; 2021 Apr; 141(4):942-946. PubMed ID: 33069729
    [No Abstract]   [Full Text] [Related]  

  • 20. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.